ArticleViruses2023

Lack of Evidence for a Role of ACE-2 Polymorphisms as a Bedside Clinical Prognostic Marker of COVID-19.

Josè R Fiore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.